APA

Minner S., Jessen B., Stiedenroth L., Burandt E., Köllermann J., Mirlacher M., Erbersdobler A., Eichelberg C., Fisch M., Brümmendorf T. H., Bokemeyer C., Simon R., Steuber T., Graefen M., Huland H., Sauter G. & Schlomm T. (20100520). Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Minner Sarah, Jessen Birte, Stiedenroth Lars, Burandt Eike, Köllermann Jens, Mirlacher Martina, Erbersdobler Andreas, Eichelberg Christian, Fisch Margit, Brümmendorf Tim Henrik, Bokemeyer Carsten, Simon Ronald, Steuber Thomas, Graefen Markus, Huland Hartwig, Sauter Guido and Schlomm Thorsten. 20100520. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Minner S., Jessen B., Stiedenroth L., Burandt E., Köllermann J., Mirlacher M., Erbersdobler A., Eichelberg C., Fisch M., Brümmendorf T. H., Bokemeyer C., Simon R., Steuber T., Graefen M., Huland H., Sauter G. and Schlomm T. (20100520). Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Minner Sarah, Jessen Birte, Stiedenroth Lars, Burandt Eike, Köllermann Jens, Mirlacher Martina, Erbersdobler Andreas, Eichelberg Christian, Fisch Margit, Brümmendorf Tim Henrik, Bokemeyer Carsten, Simon Ronald, Steuber Thomas, Graefen Markus, Huland Hartwig, Sauter Guido and Schlomm Thorsten. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20100520.